drugset / Trial / NCT00107835

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults

NCT00107835

Phase 3 Completed 408 enrolled ZARS Pharma Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in adults. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.

Timeline

Start
2005-05
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 7 % Topical
Subject tetracaine Other / unclassified 7 % Topical

Indications

No indication recorded.